---
annotation-target: 1-s2.0-S0006497122010679-main.pdf
---


>%%
>```annotation-json
>{"created":"2022-09-15T03:33:26.884Z","updated":"2022-09-15T03:33:26.884Z","document":{"title":"Endothelial-leukemia interactions remodel drug responses uncovering T-ALL vulnerabilities","link":[{"href":"urn:x-pdf:f86ebba1bbe553f4dbb0c8aafa9576a2"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010679-main.pdf"}],"documentFingerprint":"f86ebba1bbe553f4dbb0c8aafa9576a2"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010679-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010679-main.pdf","selector":[{"type":"TextPositionSelector","start":8428,"end":8449},{"type":"TextQuoteSelector","exact":" T-ALL  PDX  models  ","prefix":"oints 1  2 •  We  generated  22 ","suffix":"to  identify  T-ALL  liabilities"}]}]}
>```
>%%
>*%%PREFIX%%oints 1  2 •  We  generated  22%%HIGHLIGHT%% ==T-ALL  PDX  models== %%POSTFIX%%to  identify  T-ALL  liabilities*
>%%LINK%%[[#^unl8fx5rggi|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^unl8fx5rggi


>%%
>```annotation-json
>{"created":"2022-09-15T03:35:56.600Z","updated":"2022-09-15T03:35:56.600Z","document":{"title":"Endothelial-leukemia interactions remodel drug responses uncovering T-ALL vulnerabilities","link":[{"href":"urn:x-pdf:f86ebba1bbe553f4dbb0c8aafa9576a2"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010679-main.pdf"}],"documentFingerprint":"f86ebba1bbe553f4dbb0c8aafa9576a2"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010679-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010679-main.pdf","selector":[{"type":"TextPositionSelector","start":11676,"end":12264},{"type":"TextQuoteSelector","exact":"The  cancer  microenvironment  plays  a  critical  role15-17  in  modulating  cell 18 growth  and  therapeutic  responses16-19.  Within  the  T-ALL  niche,  collective  pro- 19 tumorigenic  signals  arise  from  multiple  cellular  and  non-cellular  components. 20 Notably, tumor-associated endothelial cells (TECs) are crucial in the pathogenesis 21 of  solid  and  liquid  malignancies20-22,  ultimately  contributing  to  multiple  pro-22 tumorigenic phenotypes. In T-ALL, TECs modulate leukemic extravasation23 and 23 tumor  aggressiveness  via  multiple  and  synergistic  mechanism","prefix":"ed clinical management 14.   17 ","suffix":"s,  including 24 SDF1α/CXCR4,  D"}]}]}
>```
>%%
>*%%PREFIX%%ed clinical management 14.   17%%HIGHLIGHT%% ==The  cancer  microenvironment  plays  a  critical  role15-17  in  modulating  cell 18 growth  and  therapeutic  responses16-19.  Within  the  T-ALL  niche,  collective  pro- 19 tumorigenic  signals  arise  from  multiple  cellular  and  non-cellular  components. 20 Notably, tumor-associated endothelial cells (TECs) are crucial in the pathogenesis 21 of  solid  and  liquid  malignancies20-22,  ultimately  contributing  to  multiple  pro-22 tumorigenic phenotypes. In T-ALL, TECs modulate leukemic extravasation23 and 23 tumor  aggressiveness  via  multiple  and  synergistic  mechanism== %%POSTFIX%%s,  including 24 SDF1α/CXCR4,  D*
>%%LINK%%[[#^63nwdy97tj7|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^63nwdy97tj7


>%%
>```annotation-json
>{"created":"2022-09-15T03:47:47.072Z","updated":"2022-09-15T03:47:47.072Z","document":{"title":"Endothelial-leukemia interactions remodel drug responses uncovering T-ALL vulnerabilities","link":[{"href":"urn:x-pdf:f86ebba1bbe553f4dbb0c8aafa9576a2"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010679-main.pdf"}],"documentFingerprint":"f86ebba1bbe553f4dbb0c8aafa9576a2"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010679-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010679-main.pdf","selector":[{"type":"TextPositionSelector","start":13027,"end":13725},{"type":"TextQuoteSelector","exact":"3,  we  developed  an  endothelial-leukemia  platform  to  explore  the 2 subverted role of tumor vascular niches. This platform integrates T-ALL patient-3 derived tumor xenografts (PDX) and ECs with drug screening libraries, ultimately 4 translating findings to in-vivo preclinical trials. This approach led to the generation 5 of  proof  of  concept  (PoC)  transcriptional  signatures  that  are  predictive  of  drug 6 response, and the selection of effective compounds/combinations in T-ALL. More 7 importantly,  we  show  that  T-ALL  and  ECs  bidirectionally  modulate  their 8 transcriptomes  and  phenotypes,  and  ECs  provide  signals  counteracting  the 9 efficacy of selected drugs.  ","prefix":" with the E4ORF1 1 (E4-ECs) 32,3","suffix":"10 Ultimately, we established an"}]}]}
>```
>%%
>*%%PREFIX%%with the E4ORF1 1 (E4-ECs) 32,3%%HIGHLIGHT%% ==3,  we  developed  an  endothelial-leukemia  platform  to  explore  the 2 subverted role of tumor vascular niches. This platform integrates T-ALL patient-3 derived tumor xenografts (PDX) and ECs with drug screening libraries, ultimately 4 translating findings to in-vivo preclinical trials. This approach led to the generation 5 of  proof  of  concept  (PoC)  transcriptional  signatures  that  are  predictive  of  drug 6 response, and the selection of effective compounds/combinations in T-ALL. More 7 importantly,  we  show  that  T-ALL  and  ECs  bidirectionally  modulate  their 8 transcriptomes  and  phenotypes,  and  ECs  provide  signals  counteracting  the 9 efficacy of selected drugs.== %%POSTFIX%%10 Ultimately, we established an*
>%%LINK%%[[#^8oftnw1tdsx|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^8oftnw1tdsx


>%%
>```annotation-json
>{"created":"2022-09-15T03:49:09.473Z","updated":"2022-09-15T03:49:09.473Z","document":{"title":"Endothelial-leukemia interactions remodel drug responses uncovering T-ALL vulnerabilities","link":[{"href":"urn:x-pdf:f86ebba1bbe553f4dbb0c8aafa9576a2"},{"href":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010679-main.pdf"}],"documentFingerprint":"f86ebba1bbe553f4dbb0c8aafa9576a2"},"uri":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010679-main.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220831/1-s2.0-S0006497122010679-main.pdf","selector":[{"type":"TextPositionSelector","start":20404,"end":20597},{"type":"TextQuoteSelector","exact":"Using  unsupervised  hierarchical  clustering  and  Principal  Component 19 Analysis  (PCA),  we  demonstrated  two  clusters  of  T-ALL  samples  based  on 20 differential  drug  susceptibilit","prefix":" with the 17 efficacy range. 18 ","suffix":"y  (Figure  1G).  Specimens  bel"}]}]}
>```
>%%
>*%%PREFIX%%with the 17 efficacy range. 18%%HIGHLIGHT%% ==Using  unsupervised  hierarchical  clustering  and  Principal  Component 19 Analysis  (PCA),  we  demonstrated  two  clusters  of  T-ALL  samples  based  on 20 differential  drug  susceptibilit== %%POSTFIX%%y  (Figure  1G).  Specimens  bel*
>%%LINK%%[[#^5uvp3l0ro4w|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^5uvp3l0ro4w
